Pyxis Oncology Analyst Ratings
Pyxis Oncology Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/05/2023 | 201.72% | RBC Capital | → $7 | Initiates Coverage On | → Outperform |
| 07/31/2023 | 546.55% | EF Hutton | → $15 | Initiates Coverage On | → Buy |
| 03/23/2023 | 503.45% | Credit Suisse | → $14 | Reiterates | → Outperform |
| 11/02/2021 | 589.66% | B of A Securities | → $16 | Initiates Coverage On | → Neutral |
| 11/02/2021 | 977.59% | Jefferies | → $25 | Initiates Coverage On | → Buy |
| 11/02/2021 | 718.97% | Credit Suisse | → $19 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 09/05/2023 | 201.72% | 加拿大皇家銀行資本 | → 7 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
| 07/31/2023 | 546.55% | EF Hutton | → 15 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 03/23/2023 | 503.45% | 瑞士信貸 | → 14 美元 | 重申 | → 跑贏大盤 |
| 11/02/2021 | 589.66% | B of A 類證券 | → 16 美元 | 啓動覆蓋範圍開啓 | → 中立 |
| 11/02/2021 | 977.59% | 傑富瑞集團 | → 25 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 11/02/2021 | 718.97% | 瑞士信貸 | → 19 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
What is the target price for Pyxis Oncology (PYXS)?
Pyxis Oncology（PYXS）的目標價格是多少？
The latest price target for Pyxis Oncology (NASDAQ: PYXS) was reported by RBC Capital on September 5, 2023. The analyst firm set a price target for $7.00 expecting PYXS to rise to within 12 months (a possible 201.72% upside). 3 analyst firms have reported ratings in the last year.
加拿大皇家銀行資本於2023年9月5日公佈了Pyxis Oncology（納斯達克股票代碼：PYXS）的最新目標股價。該分析公司將目標股價定爲7.00美元，預計PYXS將在12個月內升至12個月內（可能上漲201.72％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for Pyxis Oncology (PYXS)?
Pyxis Oncology（PYXS）的最新分析師評級是多少？
The latest analyst rating for Pyxis Oncology (NASDAQ: PYXS) was provided by RBC Capital, and Pyxis Oncology initiated their outperform rating.
加拿大皇家銀行資本對Pyxis Oncology（納斯達克股票代碼：PYXS）的最新分析師評級由加拿大皇家銀行資本提供，Pyxis Oncology啓動了跑贏大盤的評級。
When is the next analyst rating going to be posted or updated for Pyxis Oncology (PYXS)?
Pyxis Oncology（PYXS）的下一次分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pyxis Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pyxis Oncology was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Pyxis Oncology的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Pyxis Oncology的最新評級是在2023年9月5日發佈的，因此您應該預計下一個評級將在2024年9月5日左右公佈。
Is the Analyst Rating Pyxis Oncology (PYXS) correct?
分析師對Pyxis腫瘤學（PYXS）的評級是否正確？
While ratings are subjective and will change, the latest Pyxis Oncology (PYXS) rating was a initiated with a price target of $0.00 to $7.00. The current price Pyxis Oncology (PYXS) is trading at is $2.32, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Pyxis Oncology（PYXS）評級已啓動，目標股價爲0.00美元至7.00美元。目前Pyxis Oncology（PYXS）的交易價格爲2.32美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。